Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients≥ 65 years old with relapsed or refractory multiple myeloma
Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients≥ 65 years old with relapsed or refractory multiple myeloma
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2012
Authors:
Chanan-Khan, Asher A Lonial, Sagar Weber, Donna Borrello, Ivan Foà, Robin Hellmann, Andrzej Dimopoulos, Meletios Swern, Arlene S Knight, Robert
